چاپ صفحه |  صفحه نخست سامانه |  چکیده مقاله |  نویسندگان |  دانلود مقاله | دانشگاه علوم پزشکی تبریز |
| read with interest the letter of Joob and Wiwanitkit on COVID-19 and organ transplantation, published recently in the IJOTM [1]. Herein, I would like to comment on it. Viral infection is one of the most com-mon infections after kidney transplantation; it does not occur only during the first days; it occurs in later days too. Viral infection has two main effects on recipients—directly by the virus, which induces fever and leuko-penia, and indirectly through the release of cytokines [2, 3]. Therefore, recipients, health care workers, and family members of the re-cipients are still advised to receive vaccination against inf luenza before and after the trans-plantation [4]. Recipients should also receive other relevant medications, especially the im-munosuppressant agents. So it is very soon to jump to the conclusion made in their letter that COVID-19 is less common in transplant recipients and that it is associated with a good prognosis [1]; it needs more careful studies. In another letter published in the New England Journal of Medicine, 28% of kidney recipients with COVID-19 died [5]; the mortality was 1% among normal people diagnosed with CO-VID-19. The mortality was very high in our department too. We had four kidney trans-plant recipients with COVID-19; two of them died. The most common symptoms were fever and diarrhea [5]. Definitive conclusion needs extensive study in long time |
| نویسنده | نفر چندم مقاله |
|---|---|
| افشار زمردی | اول |
| نام فایل | تاریخ درج فایل | اندازه فایل | دانلود |
|---|---|---|---|
| 766-2730-1-PB.pdf | 1399/07/14 | 350219 | دانلود |
